The research project aims to develop a personalized health approach to the prevention of antibiotic resistance
The University of Liverpool (UoL) and the Liverpool School of Tropical Medicine (LSTM) received GBP 3.54 million for a research project to develop a “personalized health approach” for the prevention and treatment of antibiotic resistance (AMR).
The funding will provide equipment for real-time measurement of patient drug levels, rapid sequencing of bacteria in patients, pharmacogenetic analysis, and real-time pharmacodynamic analysis. These approaches are unified by artificial intelligence and in-depth learning in collaboration with the Department of Informatics at the University of Liverpool.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
